Home  >  News
News
+ Font Resize -

Cannabics files patent application with PCT authorities on methods for testing therapeutic effectiveness of cannabinoids for cancer patients

Tel-Aviv, Israel
Wednesday, January 3, 2018, 18:00 Hrs  [IST]

Cannabics Pharmaceuticals has announced that it has filed an international patent application with the PCT authorities on methods for testing which cannabinoids or combinations of cannabinoids are likely be effective in individual patients.

The determination is made by testing the effects of cannabinoids on CTCs (Circulating Tumor Cells) and biopsies of cancer patients. The integrated approach brings together cannabinoids research, Genetic markers, CTC counting and detection methods, and a drug sensitivity test for cannabinoids developed by Cannabics Pharmaceuticals. This unique method expands the company's proprietary technology of developing a more precise tool for personalization of cannabinoids based medicine as well as accelerating drug discovery.

Cannabics Pharmaceuticals Inc., a US based public company, is dedicated to the development of personalized anti-cancer and palliative treatments.

 

Post Your commentsPOST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
Chemspec_India-2018
IPE_2018_Banner_150X60
InnoPack-Pharma_150x60_2018
GPRS_150x60_2018
cphikorea_150x60_saffron media
Chemspec_India-2018
IPX_Logo_2018_150x60_web
CPHI18_banner_150x6
CPhI_China_150x60-2018
CPhI_Japan_150x60_2018
PharmaTech_Expo_2018
VF118_Banner_150x60_E_D2
duphat_150x60
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |